Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Despite identification of several biomarkers for HCC diagnosis, challenges such as low sensitivity and intratumoral heterogeneity have impeded early detection, highlighting the need for etiology-specific blood biomarkers. Methods: We generated whole-transcriptome sequencing (WTS) and targeted proteome data from buffy coat and plasma samples from HCC patients. By integrating etiological information on viral infection, we investigated the etiology-specific gene expression landscape at the blood level. Validation of differentially expressed genes (DEGs) was performed using publicly available RNA-seq datasets and qRT‒PCR with AUC analyses. Results: Differential expression analyses with multiomics data revealed distinct gene expression profiles between HBV-associated HCC and nonviral HCC, indicating the presence of etiology-specific blood biomarkers. The identified DEGs were validated across multiple independent datasets, underscoring their utility as biomarkers. Additionally, single-cell RNA-seq analysis of HCC confirmed differences in DEG expression across distinct immune cell types. Conclusions: Our buffy coat WTS data and plasma proteome data may serve as reliable sources for identifying etiology-specific blood biomarkers of HCC and might contribute to discovery of therapeutic targets for HCC across different etiologies.
Abstract
Background/Aims: Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Despite identification of several biomarkers for HCC diagnosis, challenges such as low sensitivity and intratumoral heterogeneity have impeded early detection, highlighting the need for etiology-specific blood biomarkers. Methods: We generated whole-transcriptome sequencing (WTS) and targeted proteome data from buffy coat and plasma samples from HCC patients. By integrating etiological information on viral infection, we investigated the etiology-specific gene expression landscape at the blood level. Validation of differentially expressed genes (DEGs) was performed using publicly available RNA-seq datasets and qRT‒PCR with AUC analyses. Results: Differential expression analyses with multiomics data revealed distinct gene expression profiles between HBV-associated HCC and nonviral HCC, indicating the presence of etiology-specific blood biomarkers. The identified DEGs were validated across multiple independent datasets, underscoring their utility as biomarkers. Additionally, single-cell RNA-seq analysis of HCC confirmed differences in DEG expression across distinct immune cell types. Conclusions: Our buffy coat WTS data and plasma proteome data may serve as reliable sources for identifying etiology-specific blood biomarkers of HCC and might contribute to discovery of therapeutic targets for HCC across different etiologies.
참고문헌 (35)
- Sankar K, "Recent advances in the management of hepatocellular carcinoma", Clin Mol Hepatol, 30, pp.1~15 (2024)
- Chidambaranathan-Reghupaty S, "Hepatocellular carcinoma(HCC) : Epidemiology, etiology and molecular classification", Adv Cancer Res, 149, pp.1~61 (2021)
- Kulik L, "Epidemiology and management of hepatocellular carcinoma", Gastroenterology, 156, pp.477~491 (2019)
- Elderkin J, "Hepatocellular carcinoma : Surveillance, diagnosis, evaluation and management", Cancers(Basel), 15, pp.5118~ (2023)
- Parikh ND, "Blood-based biomarkers for hepatocellular carcinoma screening : Approaching the end of the ultrasound era?", J Hepatol, 78, pp.207~216 (2023)
- Liu J, "The significance of intertumor and intratumor heterogeneity in liver cancer", Exp Mol Med, 50, pp.e416~ (2018)
- Kim SC, "A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma", Mol Cancer, 22, pp.164~ (2023)
- Kim DY, "Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region", Clin Mol Hepatol, 29, pp.277~292 (2023)
- Han Z, "RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma", Sci Rep, 11, pp.17797~ (2021)
- Ding Z, "Proteomics technologies for cancer liquid biopsies", Mol Cancer, 21, pp.53~ (2022)
- Kunadirek P, "Transcriptomic analyses reveal long non-coding RNA in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma", Int J Mol Sci, 23, pp.7882~ (2022)
- Li J, "FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma", Sci Rep, 13, pp.15735~ (2023)
- Song T, "Peripheral blood genetic biomarkers for the early diagnosis of hepatocellular carcinoma", Front Oncol, 11, pp.583714~ (2021)
- Donzelli S, "Use of buffy coat miRNA profiling for breast cancer prediction in healthy women", Methods Mol Biol, 1379, pp.13~19 (2016)
- Cavalcante LTF, "Buffy coat transcriptomic analysis reveals alterations in host cell protein synthesis and cell cycle in severe COVID-19 patients", Int J Mol Sci, 23, pp.13588~ (2022)
- He D, "Whole blood vs PBMC : compartmental differences in gene expression profiling exemplified in asthma", Allergy Asthma Clin Immunol, 15, pp.67~ (2019)
- Das DK, "Isolation and propagation of circulating tumor cells from a mouse cancer model", J Vis Exp, (104), pp.52861~ (2015)
- Wik L, "Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis", Mol Cell Proteomics, 20, pp.100168~ (2021)
- Roma S, "The dual role of innate lymphoid and natural killer cells in cancer. from phenotype to single-cell transcriptomics, functions and clinical uses", Cancers(Basel), 13, pp.5042~ (2021)
- Spits H, "NK cells and type 1 innate lymphoid cells : partners in host defense", Nat Immunol, 17, pp.758~764 (2016)
- Vivier E, "Innate lymphoid cells : 10 years on", Cell, 174, pp.1054~1066 (2018)
- Björklund ÅK, "The heterogeneity of human CD127(+)innate lymphoid cells revealed by single-cell RNA sequencing", Nat Immunol, 17, pp.451~460 (2016)
- Sun Z, "CD160 Promotes NK cell functions by upregulating glucose metabolism and negatively correlates with HIV disease progression", Front Immunol, 13, pp.854432~ (2022)
- Plaisier SB, "Rank-rank hypergeometric overlap : identification of statistically significant overlap between gene-expression signatures", Nucleic Acids Res, 38, pp.e169~ (2010)
- Korean Liver Cancer Association(KLCA)and National Cancer Center(NCC)Korea, "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Clin Mol Hepatol, 28, pp.583~705 (2022)
- Seif El Dahan K, "Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease", Clin Mol Hepatol, 29(Suppl), pp.S207~S219 (2023)
- Sohn W, "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease", Clin Mol Hepatol, 28, pp.851~863 (2022)
- Paslaru L, "Comparative RNA-sequencing analysis reveals high complexity and heterogeneity of transcriptomic and immune profiles in hepatocellular carcinoma tumors of viral(HBV, HCV)and non-viral etiology", Medicina(Kaunas), 58, pp.1803~ (2022)
- Lim CJ, "Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma", Gut, 68, pp.916~927 (2019)
- Van Thiel DH, "Non-viral causes of hepatocellular carcinoma", J Gastrointest Cancer, 42, pp.191~194 (2011)
- Kudo Y, "PKCλ", ι loss induces autophagy, oxidative phosphorylation, and NRF2 to promote liver cancer progression, 2020, pp.38, 247~262
- Tenen DG, "Metabolic alterations and vulnerabilities in hepatocellular carcinoma", Gastroenterol Rep(Oxf), 9, pp.1~13 (2020)
- Meyer T, "Aetiology of liver disease and response to immune checkpoint inhibitors : An updated meta-analysis confirms benefit in those with non-viral liver disease", J Hepatol, 79, pp.e73~e76 (2023)
- Jacobs J, "CD70 : An emerging target in cancer immunotherapy", Pharmacol Ther, 155, pp.1~10 (2015)
- Gao X, "ABC portal : a single-cell database and web server for blood cells", Nucleic Acids Res, 51, pp.D792~D804 (2023)